1. Home
  2. XENE vs OUT Comparison

XENE vs OUT Comparison

Compare XENE & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • OUT
  • Stock Information
  • Founded
  • XENE 1996
  • OUT 2013
  • Country
  • XENE Canada
  • OUT United States
  • Employees
  • XENE N/A
  • OUT N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • OUT Real Estate Investment Trusts
  • Sector
  • XENE Health Care
  • OUT Real Estate
  • Exchange
  • XENE Nasdaq
  • OUT Nasdaq
  • Market Cap
  • XENE 2.3B
  • OUT 2.4B
  • IPO Year
  • XENE 2014
  • OUT N/A
  • Fundamental
  • Price
  • XENE $32.05
  • OUT $15.79
  • Analyst Decision
  • XENE Strong Buy
  • OUT Buy
  • Analyst Count
  • XENE 11
  • OUT 8
  • Target Price
  • XENE $54.82
  • OUT $18.73
  • AVG Volume (30 Days)
  • XENE 977.8K
  • OUT 1.3M
  • Earning Date
  • XENE 08-07-2025
  • OUT 08-05-2025
  • Dividend Yield
  • XENE N/A
  • OUT 7.59%
  • EPS Growth
  • XENE N/A
  • OUT N/A
  • EPS
  • XENE N/A
  • OUT 1.53
  • Revenue
  • XENE $7,500,000.00
  • OUT $1,813,100,000.00
  • Revenue This Year
  • XENE N/A
  • OUT N/A
  • Revenue Next Year
  • XENE $253.71
  • OUT $2.85
  • P/E Ratio
  • XENE N/A
  • OUT $10.30
  • Revenue Growth
  • XENE N/A
  • OUT N/A
  • 52 Week Low
  • XENE $26.74
  • OUT $12.95
  • 52 Week High
  • XENE $46.00
  • OUT $19.98
  • Technical
  • Relative Strength Index (RSI)
  • XENE 51.34
  • OUT 45.47
  • Support Level
  • XENE $31.22
  • OUT $15.62
  • Resistance Level
  • XENE $33.46
  • OUT $16.14
  • Average True Range (ATR)
  • XENE 1.28
  • OUT 0.36
  • MACD
  • XENE 0.27
  • OUT -0.10
  • Stochastic Oscillator
  • XENE 68.60
  • OUT 16.53

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About OUT OUTFRONT Media Inc.

Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.

Share on Social Networks: